Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,2.5168025983756717e-57,54.229866024386574,7067.472637553269,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL22', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",7.147719379386908e-55,0,0,69
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.173678967916465e-28,18.59863724853991,1196.1200107088423,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'ATP5F1A', 'ATP5F1B', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'SURF1', 'ATP5PD', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'ATP5F1D', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'ATP5PO', 'SLC25A5']",1.6666241344413803e-26,0,0,44
3,Nonalcoholic fatty liver disease WP4396,5.766710741534349e-16,7.6308823529411764,267.76201210404014,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB7', 'NDUFA11', 'UQCRB', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX6A1', 'COX5B', 'COX7A1', 'COX7C', 'COX5A', 'UQCRH', 'NDUFA5', 'NDUFA4', 'NDUFA1', 'NDUFC1', 'COX6C', 'EIF2S1', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS3', 'CYCS']",5.459152835319184e-14,0,0,36
4,Oxidative phosphorylation WP623,8.167049848014234e-15,14.077338129496402,456.65010701400325,"['NDUFB9', 'ATP5PF', 'NDUFB7', 'ATP5PD', 'NDUFA11', 'NDUFB10', 'NDUFA5', 'NDUFB5', 'NDUFA4', 'NDUFB2', 'NDUFB1', 'NDUFC1', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'NDUFS6', 'NDUFS5', 'NDUFS3', 'ATP5PO', 'ATP5MG', 'ATP5MF', 'ATP5ME']",5.798605392090106e-13,0,0,24
5,Mitochondrial CIV Assembly WP4922,1.0271652548995368e-09,13.869026548672567,287.03979493022314,"['COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX7A2', 'COX6A1', 'COX5B', 'COX6C', 'COX5A', 'COX7C', 'COX6B1', 'COX14', 'SMIM20', 'COX20']",5.834298647829369e-08,0,0,15
6,Mitochondrial complex I assembly model OXPHOS system WP4324,1.9445828273047754e-09,9.84746891651865,197.52268189526436,"['NDUFB9', 'NDUFA13', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFS3']",9.20435871590927e-08,0,0,17
7,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.0036582776380152363,27.20797227036395,152.65747957687677,"['GSTP1', 'EPHX2', 'COX5A']",0.12986885614954088,0,0,3
8,Glutathione metabolism WP100,0.0036582776380152363,27.20797227036395,152.65747957687677,"['GPX4', 'IDH1', 'GSS']",0.12986885614954088,0,0,3
9,Mitochondrial complex III assembly WP4921,0.0042370135666204576,6.493167701863354,35.47799696452151,"['UQCRB', 'UQCRQ', 'UQCR11', 'UQCR10', 'UQCRH']",0.13370131699113444,0,0,5
10,Cellular Proteostasis WP4918,0.015688484302607043,9.065857885615252,37.66708308525047,"['VBP1', 'PFDN4', 'PFDN6']",0.44555295419404,0,0,3
11,Selenium Micronutrient Network WP15,0.01781126378682171,3.40897212543554,13.731081405720827,"['SELENOM', 'PRDX5', 'GPX4', 'SELENOW', 'SELENOK', 'SELENOH']",0.45985444685976046,0,0,6
12,Nanomaterial induced apoptosis WP2507,0.025442967632408994,6.798093587521664,24.957949044219983,"['ENDOG', 'CASP6', 'CYCS']",0.4940323556679782,0,0,3
13,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.025442967632408994,6.798093587521664,24.957949044219983,"['EIF3I', 'EIF2S1', 'EIF3D']",0.4940323556679782,0,0,3
14,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.027717668507026377,3.4923076923076923,12.52231606514207,"['OTUD5', 'CYLD', 'IRF3', 'TRAF3', 'PIN1']",0.4940323556679782,0,0,5
15,Apoptosis Modulation by HSP70 WP384,0.027832808770026942,18.10726643598616,64.85189509384162,"['CASP6', 'CYCS']",0.4940323556679782,0,0,2
16,Cytosine methylation WP3585,0.027832808770026942,18.10726643598616,64.85189509384162,"['IDH1', 'TDG']",0.4940323556679782,0,0,2
17,Translation Factors WP107,0.03909603197869131,2.725087108013937,8.834008351429528,"['EEF1B2', 'EIF2AK1', 'EIF3I', 'EIF2B1', 'EIF2S1', 'EIF3D']",0.6531337107028431,0,0,6
18,One-carbon metabolism and related pathways WP3940,0.06764645176562047,3.021990740740741,8.139612315678276,"['GPX4', 'CHKA', 'GSS', 'ETNK1']",0.9347340432497457,0,0,4
19,Oxidative Damage WP3941,0.06961352607602266,3.8823966328299084,10.345796533074576,"['BAD', 'TRAF3', 'CYCS']",0.9347340432497457,0,0,3
20,Synaptic Vesicle Pathway WP2267,0.07211505761013526,2.519806763285024,6.625812766491135,"['SLC32A1', 'AP2S1', 'PARK7', 'SYP', 'AP2M1']",0.9347340432497457,0,0,5
21,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.07211505761013526,2.519806763285024,6.625812766491135,"['PPP1R3F', 'MAP1LC3A', 'EIF2AK1', 'DDIT3', 'EIF2S1']",0.9347340432497457,0,0,5
22,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.08103356121195832,6.033448673587082,15.16140414509704,"['MAP1LC3A', 'ATG7']",0.9347340432497457,0,0,2
23,Kennedy pathway from sphingolipids WP3933,0.08103356121195832,6.033448673587082,15.16140414509704,"['CHKA', 'ETNK1']",0.9347340432497457,0,0,2
24,Nanoparticle triggered autophagic cell death WP2509,0.08103356121195832,6.033448673587082,15.16140414509704,"['MAP1LC3A', 'ATG7']",0.9347340432497457,0,0,2
25,Apoptosis WP254,0.08396452154859604,2.3867276887871856,5.912785931227377,"['IRF3', 'CASP6', 'TRAF3', 'BAD', 'CYCS']",0.9347340432497457,0,0,5
26,Metapathway biotransformation Phase I and II WP702,0.08784505241087094,1.9859293193717278,4.830139130023245,"['CYP4Z1', 'CYP4X1', 'GPX4', 'GSTO1', 'EPHX2', 'GSTP1', 'GSS']",0.9347340432497457,0,0,7
27,SARS-CoV-2 mitochondrial interactions WP5038,0.08886556044979976,3.3964471403812824,8.221543906579479,"['NDUFB9', 'IRF3', 'TRAF3']",0.9347340432497457,0,0,3
28,Base Excision Repair WP4752,0.09720965528907112,2.5892857142857144,6.035327848909059,"['POLE4', 'NEIL2', 'MPG', 'TDG']",0.976949709349421,0,0,4
29,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.09975894919413103,inf,inf,['TRAF3'],0.976949709349421,0,0,1
30,SARS coronavirus and innate immunity WP4912,0.11370613008677476,4.524221453287197,9.836281624145645,"['IRF3', 'TRAF3']",0.9965465294843274,0,0,2
31,Ferroptosis WP4313,0.1317482384211961,2.2647569444444446,4.590350836853318,"['MAP1LC3A', 'GPX4', 'GSS', 'ATG7']",0.9965465294843274,0,0,4
32,Apoptosis Modulation and Signaling WP1772,0.14057495470014744,1.9701323251417768,3.8654280845299205,"['ENDOG', 'CASP6', 'TRAF3', 'BAD', 'CYCS']",0.9965465294843274,0,0,5
33,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.149011416722346,3.6186851211072666,6.8890079428120385,"['IRF3', 'TRAF3']",0.9965465294843274,0,0,2
34,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.149011416722346,3.6186851211072666,6.8890079428120385,"['FGF1', 'GTPBP4']",0.9965465294843274,0,0,2
35,Ciliary landscape WP4352,0.15418984180942635,1.4532394366197183,2.7169338660586444,"['MYL6', 'NDUFA5', 'SSNA1', 'TNKS1BP1', 'COPS7A', 'MYL6B', 'SNRPB2', 'WDR34', 'COX6C', 'DCAF11', 'LSM4', 'SPATA7']",0.9965465294843274,0,0,12
36,Proteasome Degradation WP183,0.1568128767927928,1.8876811594202898,3.497310757645164,"['PSMC5', 'PSMB5', 'H2AFZ', 'HLA-B', 'PSMB10']",0.9965465294843274,0,0,5
37,Histone Modifications WP2369,0.15732773162809316,2.4687253820702693,4.5657204320623155,"['SET', 'SETDB2', 'KMT5A']",0.9965465294843274,0,0,3
38,Regulation of toll-like receptor signaling pathway WP1449,0.15785519678354387,1.7544115994155334,3.2387791517435534,"['OTUD5', 'CYLD', 'IRF3', 'TRAF3', 'SQSTM1', 'RNF41']",0.9965465294843274,0,0,6
39,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.18293266424925295,2.2625649913344885,3.843276945798218,"['DEPTOR', 'MAP1LC3A', 'ATG7']",0.9965465294843274,0,0,3
40,Parkinson's disease pathway WP2371,0.18293266424925295,2.2625649913344885,3.843276945798218,"['CASP6', 'CYCS', 'PARK7']",0.9965465294843274,0,0,3
41,Hippo-Yap signaling pathway WP4537,0.18610112632966364,3.0149942329873127,5.069607468126711,"['NF2', 'STK3']",0.9965465294843274,0,0,2
42,MTHFR deficiency WP4288,0.18610112632966364,3.0149942329873127,5.069607468126711,"['CHKA', 'CYCS']",0.9965465294843274,0,0,2
43,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.1895816016329728,9.037996545768566,15.029607398672777,['GSS'],0.9965465294843274,0,0,1
44,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.1895816016329728,9.037996545768566,15.029607398672777,['ELOB'],0.9965465294843274,0,0,1
45,NAD+ metabolism WP3644,0.1895816016329728,9.037996545768566,15.029607398672777,['NAMPT'],0.9965465294843274,0,0,1
46,Eukaryotic Transcription Initiation WP405,0.1912475717015556,1.9060672514619883,3.1529907218295152,"['TAF13', 'POLR1B', 'POLR2I', 'POLR2K']",0.9965465294843274,0,0,4
47,7q11.23 copy number variation syndrome WP4932,0.19758861384857776,1.5473119652662495,2.509071750783082,"['ATP5F1A', 'ATP5F1B', 'ATP5PO', 'SQSTM1', 'ATP5F1D', 'ATP5F1E', 'ATP5MC1']",0.9965465294843274,0,0,7
48,GABA receptor Signaling WP4159,0.20953717969084565,2.088121583788828,3.2634293506971037,"['SLC32A1', 'AP2S1', 'AP2M1']",0.9965465294843274,0,0,3
49,Autophagy WP4923,0.22426952890016208,2.583786455758774,3.8625196748807813,"['DEPTOR', 'ATG7']",0.9965465294843274,0,0,2
50,Toll-like Receptor Signaling related to MyD88 WP3858,0.22426952890016208,2.583786455758774,3.8625196748807813,"['IRF3', 'TRAF3']",0.9965465294843274,0,0,2
51,Hematopoietic Stem Cell Differentiation WP2849,0.22426952890016208,2.583786455758774,3.8625196748807813,"['SEC14L2', 'ACVR1B']",0.9965465294843274,0,0,2
52,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.22426952890016208,2.583786455758774,3.8625196748807813,"['B4GALT2', 'B3GALT2']",0.9965465294843274,0,0,2
53,DNA Repair Pathways Full Network WP4946,0.25457016712614317,1.4682173462661268,2.008783810528936,"['POLE4', 'DCLRE1C', 'NEIL2', 'MPG', 'TDG', 'GTF2H5']",0.9965465294843274,0,0,6
54,TLR4 Signaling and Tolerance WP3851,0.2629335322085965,2.26038062283737,3.0195385146017486,"['IRF3', 'TRAF3']",0.9965465294843274,0,0,2
55,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.2629335322085965,2.26038062283737,3.0195385146017486,"['IFITM3', 'DDIT3']",0.9965465294843274,0,0,2
56,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.2629335322085965,2.26038062283737,3.0195385146017486,"['NF2', 'STK3']",0.9965465294843274,0,0,2
57,Oxidation by Cytochrome P450 WP43,0.2629335322085965,2.26038062283737,3.0195385146017486,"['CYP4Z1', 'CYP4X1']",0.9965465294843274,0,0,2
58,PKC-gamma calcium signaling pathway in ataxia WP4760,0.2629335322085965,2.26038062283737,3.0195385146017486,"['PRKCG', 'TRPC3']",0.9965465294843274,0,0,2
59,Cytosolic DNA-sensing pathway WP4655,0.2648578813868268,1.8090121317157712,2.4033845830910407,"['CYLD', 'IRF3', 'POLR2K']",0.9965465294843274,0,0,3
60,Modulators of TCR signaling and T cell activation WP5072,0.2648578813868268,1.8090121317157712,2.4033845830910407,"['NDUFB10', 'ELOB', 'RNF7']",0.9965465294843274,0,0,3
61,Caloric restriction and aging WP4191,0.2704560107394013,4.518134715025907,5.908119956026845,['NAMPT'],0.9965465294843274,0,0,1
62,Cell Differentiation - Index WP2029,0.2704560107394013,4.518134715025907,5.908119956026845,['LEFTY1'],0.9965465294843274,0,0,1
63,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.2704560107394013,4.518134715025907,5.908119956026845,['EPHX2'],0.9965465294843274,0,0,1
64,Non-homologous end joining WP438,0.2704560107394013,4.518134715025907,5.908119956026845,['DCLRE1C'],0.9965465294843274,0,0,1
65,White fat cell differentiation WP4149,0.30161530186034147,2.0088427527873893,2.4078047662585886,"['IRF3', 'DDIT3']",0.9965465294843274,0,0,2
66,Fas ligand pathway and stress induction of heat shock proteins WP314,0.30161530186034147,2.0088427527873893,2.4078047662585886,"['CASP6', 'CYCS']",0.9965465294843274,0,0,2
67,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.30161530186034147,2.0088427527873893,2.4078047662585886,"['IRF3', 'TRAF3']",0.9965465294843274,0,0,2
68,Acetylcholine Synthesis WP528,0.34327220894608645,3.0115141047783536,3.220005847336359,['CHKA'],0.9965465294843274,0,0,1
69,Transcription co-factors SKI and SKIL protein partners WP4533,0.34327220894608645,3.0115141047783536,3.220005847336359,['STK3'],0.9965465294843274,0,0,1
70,Dual hijack model of Vif in HIV infection WP3300,0.34327220894608645,3.0115141047783536,3.220005847336359,['ELOB'],0.9965465294843274,0,0,1
71,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.34327220894608645,3.0115141047783536,3.220005847336359,['SQSTM1'],0.9965465294843274,0,0,1
72,Pyrimidine metabolism WP4022,0.3483197754601674,1.329923273657289,1.4025827355218055,"['POLE4', 'POLR1B', 'NME3', 'POLR2I', 'POLR2K']",0.9965465294843274,0,0,5
73,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.3501455083022918,1.5066435586366262,1.581081502767127,"['BEX3', 'RNF7', 'SQSTM1']",0.9965465294843274,0,0,3
74,Exercise-induced Circadian Regulation WP410,0.3501455083022918,1.5066435586366262,1.581081502767127,"['DAZAP2', 'SUMO1', 'GSTP1']",0.9965465294843274,0,0,3
75,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.35078878985667955,1.391025641025641,1.4571980869267007,"['PRKCG', 'BAD', 'RPS6', 'PDGFC']",0.9965465294843274,0,0,4
76,mRNA Processing WP411,0.3571060130993901,1.2415220887656984,1.2784233356021328,"['LSM7', 'SF3A1', 'CELF1', 'HNRNPA2B1', 'SNRPG', 'SNRPB2', 'DNAJC8']",0.9965465294843274,0,0,7
77,Alzheimer's disease WP2059,0.37440128422465685,1.3392489711934157,1.3157144887027636,"['ATP5MD', 'APH1A', 'BAD', 'CYCS']",0.9965465294843274,0,0,4
78,Type 2 papillary renal cell carcinoma WP4241,0.37755820659368894,1.6429694872601448,1.6003024446014535,"['COL21A1', 'ELOB']",0.9965465294843274,0,0,2
79,Unfolded protein response WP4925,0.37755820659368894,1.6429694872601448,1.6003024446014535,"['DDIT3', 'EIF2S1']",0.9965465294843274,0,0,2
80,Complement system WP2806,0.37755820659368894,1.6429694872601448,1.6003024446014535,"['RPS19', 'CD59']",0.9965465294843274,0,0,2
81,Differentiation Pathway WP2848,0.37755820659368894,1.6429694872601448,1.6003024446014535,"['LEFTY1', 'FGF1']",0.9965465294843274,0,0,2
82,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.37755820659368894,1.6429694872601448,1.6003024446014535,"['RAB4A', 'RABAC1']",0.9965465294843274,0,0,2
83,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.37755820659368894,1.6429694872601448,1.6003024446014535,"['IRF3', 'TRAF3']",0.9965465294843274,0,0,2
84,DNA IR-double strand breaks and cellular response via ATM WP3959,0.3785060232211717,1.4270728815105354,1.386434544958042,"['DCLRE1C', 'TRIM28', 'STK3']",0.9965465294843274,0,0,3
85,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.4088318520825777,2.2582037996545767,2.019853385406094,['IRF3'],0.9965465294843274,0,0,1
86,Transcriptional cascade regulating adipogenesis WP4211,0.4088318520825777,2.2582037996545767,2.019853385406094,['DDIT3'],0.9965465294843274,0,0,1
87,Cysteine and methionine catabolism WP4504,0.4088318520825777,2.2582037996545767,2.019853385406094,['GSS'],0.9965465294843274,0,0,1
88,Glial Cell Differentiation WP2276,0.4088318520825777,2.2582037996545767,2.019853385406094,['MBP'],0.9965465294843274,0,0,1
89,Insulin signaling in adipocytes (diabetic condition) WP3635,0.4088318520825777,2.2582037996545767,2.019853385406094,['RPS6'],0.9965465294843274,0,0,1
90,Insulin signaling in adipocytes (normal condition) WP3634,0.4088318520825777,2.2582037996545767,2.019853385406094,['RPS6'],0.9965465294843274,0,0,1
91,"NAD metabolism, sirtuins and aging WP3630",0.4088318520825777,2.2582037996545767,2.019853385406094,['NAMPT'],0.9965465294843274,0,0,1
92,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.4088318520825777,2.2582037996545767,2.019853385406094,['IRF3'],0.9965465294843274,0,0,1
93,VEGFA-VEGFR2 Signaling Pathway WP3888,0.41098534092531286,1.0855516014234876,0.9652700219225647,"['RPL5', 'RAB4A', 'SET', 'TRPC3', 'RPS6', 'RPL10A', 'PDIA6', 'RPL7', 'RCN1', 'RPL18A', 'AP2S1', 'RPLP2', 'CYCS', 'RPL27', 'RPL26', 'CCT7', 'EIF3D', 'PTMA']",0.9965465294843274,0,0,18
94,Amyotrophic lateral sclerosis (ALS) WP2447,0.41426327427439286,1.5057670126874279,1.3269625691830536,"['TOMM40', 'BAD']",0.9965465294843274,0,0,2
95,CAMKK2  Pathway WP4874,0.41426327427439286,1.5057670126874279,1.3269625691830536,"['MAP1LC3A', 'SQSTM1']",0.9965465294843274,0,0,2
96,NO/cGMP/PKG mediated Neuroprotection WP4008,0.41426327427439286,1.5057670126874279,1.3269625691830536,"['BAD', 'CYCS']",0.9965465294843274,0,0,2
97,3q29 copy number variation syndrome WP4906,0.4342934297662422,1.2906660064372368,1.0764604521636831,"['DLG1', 'NF2', 'WDR34']",0.9965465294843274,0,0,3
98,Acute viral myocarditis WP4298,0.4342934297662422,1.2906660064372368,1.0764604521636831,"['ENDOG', 'CASP6', 'CYCS']",0.9965465294843274,0,0,3
99,Serotonin and anxiety-related events WP3944,0.46785697130884063,1.806217616580311,1.3719896197793342,['CRH'],0.9965465294843274,0,0,1
100,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.46785697130884063,1.806217616580311,1.3719896197793342,['SST'],0.9965465294843274,0,0,1
101,Thiamine metabolic pathways WP4297,0.46785697130884063,1.806217616580311,1.3719896197793342,['BCKDK'],0.9965465294843274,0,0,1
102,Oxidative Stress WP408,0.46785697130884063,1.806217616580311,1.3719896197793342,['TXN2'],0.9965465294843274,0,0,1
103,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.4841833416711396,1.2901631240731586,0.9357445266923807,"['DEPTOR', 'MAP1LC3A']",0.9965465294843274,0,0,2
104,Photodynamic therapy-induced unfolded protein response WP3613,0.4841833416711396,1.2901631240731586,0.9357445266923807,"['DDIT3', 'PDIA6']",0.9965465294843274,0,0,2
105,Non-small cell lung cancer WP4255,0.48812265642391783,1.1779820661592948,0.8448352612397464,"['PRKCG', 'BAD', 'CYCS']",0.9965465294843274,0,0,3
106,Senescence and Autophagy in Cancer WP615,0.5120019867005465,1.094486531986532,0.732678587939198,"['GABARAPL1', 'MAP1LC3A', 'SQSTM1', 'ATG7']",0.9965465294843274,0,0,4
107,Pathways Regulating Hippo Signaling WP4540,0.5120019867005465,1.094486531986532,0.732678587939198,"['PRKCG', 'CDH11', 'NF2', 'STK3']",0.9965465294843274,0,0,4
108,ErbB signaling pathway WP673,0.5140897855600934,1.1286828422876949,0.750977423471962,"['PRKCG', 'BTC', 'BAD']",0.9965465294843274,0,0,3
109,Development of ureteric collection system WP5053,0.517152235170772,1.203921568627451,0.7938875397870516,"['GDF11', 'FAT4']",0.9965465294843274,0,0,2
110,Cell Differentiation - Index expanded WP2023,0.5209978680993461,1.5048934945308001,0.9812045978518235,['LEFTY1'],0.9965465294843274,0,0,1
111,Tryptophan catabolism leading to NAD+ production WP4210,0.5209978680993461,1.5048934945308001,0.9812045978518235,['NAMPT'],0.9965465294843274,0,0,1
112,Type II diabetes mellitus WP1584,0.5209978680993461,1.5048934945308001,0.9812045978518235,['SURF1'],0.9965465294843274,0,0,1
113,Urea cycle and metabolism of amino groups WP497,0.5209978680993461,1.5048934945308001,0.9812045978518235,['ODC1'],0.9965465294843274,0,0,1
114,Glycerolipids and Glycerophospholipids WP4722,0.5209978680993461,1.5048934945308001,0.9812045978518235,['ETNK1'],0.9965465294843274,0,0,1
115,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.5209978680993461,1.5048934945308001,0.9812045978518235,['BAD'],0.9965465294843274,0,0,1
116,Kynurenine Pathway and links to Cellular Senescence WP5044,0.5209978680993461,1.5048934945308001,0.9812045978518235,['EIF2AK1'],0.9965465294843274,0,0,1
117,miRNAs involvement in the immune response in sepsis WP4329,0.5209978680993461,1.5048934945308001,0.9812045978518235,['TRAF3'],0.9965465294843274,0,0,1
118,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5209978680993461,1.5048934945308001,0.9812045978518235,['NAMPT'],0.9965465294843274,0,0,1
119,NAD+ biosynthetic pathways WP3645,0.5209978680993461,1.5048934945308001,0.9812045978518235,['NAMPT'],0.9965465294843274,0,0,1
120,Ebola Virus Pathway on Host WP4217,0.5336741827455149,1.0620915032679739,0.666961357989749,"['IRF3', 'HLA-B', 'DAB2IP', 'EIF2S1']",0.9965465294843274,0,0,4
121,ATM Signaling Network in Development and Disease  WP3878,0.5486890106034217,1.1284602076124568,0.6773282938715718,"['DCLRE1C', 'TRIM28']",0.9965465294843274,0,0,2
122,Kit receptor signaling pathway WP304,0.5486890106034217,1.1284602076124568,0.6773282938715718,"['BAD', 'RPS6']",0.9965465294843274,0,0,2
123,Nephrotic syndrome WP4758,0.5486890106034217,1.1284602076124568,0.6773282938715718,"['COL4A4', 'ZMPSTE24']",0.9965465294843274,0,0,2
124,Regulatory circuits of the STAT3 signaling pathway WP4538,0.5486890106034217,1.1284602076124568,0.6773282938715718,"['DEPTOR', 'TRIM28']",0.9965465294843274,0,0,2
125,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.5487101225899984,1.0256916996047432,0.6156047591606344,"['DLG1', 'BAD', 'RPS6', 'SQSTM1', 'EIF2S1']",0.9965465294843274,0,0,5
126,16p11.2 distal deletion syndrome WP4950,0.5688402282589151,1.2896619787811499,0.7275701282968853,['RAB4A'],0.9965465294843274,0,0,1
127,Serotonin and anxiety WP3947,0.5688402282589151,1.2896619787811499,0.7275701282968853,['CRH'],0.9965465294843274,0,0,1
128,Sleep regulation WP3591,0.5688402282589151,1.2896619787811499,0.7275701282968853,['CRH'],0.9965465294843274,0,0,1
129,Cell migration and invasion through p75NTR WP4561,0.5688402282589151,1.2896619787811499,0.7275701282968853,['CDH11'],0.9965465294843274,0,0,1
130,Type II interferon signaling (IFNG) WP619,0.5688402282589151,1.2896619787811499,0.7275701282968853,['HLA-B'],0.9965465294843274,0,0,1
131,DNA Mismatch Repair WP531,0.5688402282589151,1.2896619787811499,0.7275701282968853,['POLE4'],0.9965465294843274,0,0,1
132,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.5688402282589151,1.2896619787811499,0.7275701282968853,['RPS6'],0.9965465294843274,0,0,1
133,miRNA regulation of p53 pathway in prostate cancer WP3982,0.5688402282589151,1.2896619787811499,0.7275701282968853,['SHISA5'],0.9965465294843274,0,0,1
134,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.5688402282589151,1.2896619787811499,0.7275701282968853,['STK3'],0.9965465294843274,0,0,1
135,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.5688402282589151,1.2896619787811499,0.7275701282968853,['GSTP1'],0.9965465294843274,0,0,1
136,Pregnane X receptor pathway WP2876,0.5688402282589151,1.2896619787811499,0.7275701282968853,['PSMC5'],0.9965465294843274,0,0,1
137,RANKL/RANK signaling pathway WP2018,0.5787509185332563,1.0618766537756972,0.5807223818826368,"['TRAF3', 'SQSTM1']",0.9965465294843274,0,0,2
138,Regulation of Microtubule Cytoskeleton WP2038,0.5787509185332563,1.0618766537756972,0.5807223818826368,"['PARD6A', 'MAPRE1']",0.9965465294843274,0,0,2
139,MECP2 and Associated Rett Syndrome WP3584,0.5874867932563206,1.0026959368380512,0.5333354856627212,"['SST', 'RPS6', 'MBP']",0.9965465294843274,0,0,3
140,Hepatitis B infection WP4666,0.6032084658137057,0.9596669750231267,0.4851043888438452,"['PRKCG', 'IRF3', 'TRAF3', 'BAD', 'CYCS']",0.9965465294843274,0,0,5
141,MET in type 1 papillary renal cell carcinoma WP4205,0.6073179427474322,1.0026912725874664,0.5000449766609925,"['BAD', 'RPL11']",0.9965465294843274,0,0,2
142,Nucleotide Excision Repair WP4753,0.6073179427474322,1.0026912725874664,0.5000449766609925,"['POLE4', 'GTF2H5']",0.9965465294843274,0,0,2
143,16p11.2 proximal deletion syndrome WP4949,0.6103173670202324,0.966699678138153,0.47733327747478627,"['TMEM219', 'SEZ6L2', 'CCT7']",0.9965465294843274,0,0,3
144,Amino Acid metabolism WP3925,0.6103173670202324,0.966699678138153,0.47733327747478627,"['IDH1', 'GSS', 'ODC1']",0.9965465294843274,0,0,3
145,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.6119115324400222,1.128238341968912,0.5541540755038633,['RPS6'],0.9965465294843274,0,0,1
146,Trans-sulfuration and one-carbon metabolism WP2525,0.6119115324400222,1.128238341968912,0.5541540755038633,['GSS'],0.9965465294843274,0,0,1
147,Gastric Cancer Network 2 WP2363,0.6119115324400222,1.128238341968912,0.5541540755038633,['OTUD5'],0.9965465294843274,0,0,1
148,GDNF/RET signaling axis WP4830,0.6119115324400222,1.128238341968912,0.5541540755038633,['FAT4'],0.9965465294843274,0,0,1
149,IL-7 signaling pathway WP205,0.6119115324400222,1.128238341968912,0.5541540755038633,['BAD'],0.9965465294843274,0,0,1
150,Nanoparticle-mediated activation of receptor signaling WP2643,0.6119115324400222,1.128238341968912,0.5541540755038633,['TLN1'],0.9965465294843274,0,0,1
151,Neural Crest Cell Migration during Development WP4564,0.6119115324400222,1.128238341968912,0.5541540755038633,['CDH11'],0.9965465294843274,0,0,1
152,Neural Crest Cell Migration in Cancer WP4565,0.6119115324400222,1.128238341968912,0.5541540755038633,['CDH11'],0.9965465294843274,0,0,1
153,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.6119115324400222,1.128238341968912,0.5541540755038633,['MBP'],0.9965465294843274,0,0,1
154,Adipogenesis WP236,0.6340867143642622,0.9250356125356125,0.4214180674056077,"['CELF1', 'DDIT3', 'NAMPT', 'ZMPSTE24']",0.9965465294843274,0,0,4
155,7-oxo-C and 7beta-HC pathways WP5064,0.6506868313085189,1.0026866244482824,0.4308813249718088,['EPHX2'],0.9965465294843274,0,0,1
156,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.6506868313085189,1.0026866244482824,0.4308813249718088,['TRAF3'],0.9965465294843274,0,0,1
157,TP53 network WP1742,0.6506868313085189,1.0026866244482824,0.4308813249718088,['SUMO1'],0.9965465294843274,0,0,1
158,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.6506868313085189,1.0026866244482824,0.4308813249718088,['H2AFZ'],0.9965465294843274,0,0,1
159,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.6506868313085189,1.0026866244482824,0.4308813249718088,['BAD'],0.9965465294843274,0,0,1
160,Small cell lung cancer WP4658,0.6533835688198963,0.9019064124783363,0.38384318645223875,"['TRAF3', 'COL4A4', 'CYCS']",0.9965465294843274,0,0,3
161,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.6599769481561129,0.9020761245674741,0.37485806878255745,"['BAD', 'CYCS']",0.9965465294843274,0,0,2
162,Endometrial cancer WP4155,0.6599769481561129,0.9020761245674741,0.37485806878255745,"['BAD', 'FGF1']",0.9965465294843274,0,0,2
163,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.6599769481561129,0.9020761245674741,0.37485806878255745,"['PRKCG', 'IFI27L2']",0.9965465294843274,0,0,2
164,22q11.2 copy number variation syndrome WP4657,0.684108559216561,0.8589553468446202,0.326092658291604,"['RANBP1', 'MRPL40']",0.9965465294843274,0,0,2
165,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.684108559216561,0.8589553468446202,0.326092658291604,"['COL4A4', 'TLN1']",0.9965465294843274,0,0,2
166,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.6855939487673667,0.902245250431779,0.3405702782225799,['IDH3G'],0.9965465294843274,0,0,1
167,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.6855939487673667,0.902245250431779,0.3405702782225799,['IDH1'],0.9965465294843274,0,0,1
168,BDNF-TrkB Signaling WP3676,0.6855939487673667,0.902245250431779,0.3405702782225799,['TRPC3'],0.9965465294843274,0,0,1
169,Fatty acid beta-oxidation WP143,0.6855939487673667,0.902245250431779,0.3405702782225799,['CPT1B'],0.9965465294843274,0,0,1
170,Fluoropyrimidine Activity WP1601,0.6855939487673667,0.902245250431779,0.3405702782225799,['TDG'],0.9965465294843274,0,0,1
171,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.6855939487673667,0.902245250431779,0.3405702782225799,['RPS6'],0.9965465294843274,0,0,1
172,IL17 signaling pathway WP2112,0.6855939487673667,0.902245250431779,0.3405702782225799,['TRAF3'],0.9965465294843274,0,0,1
173,Methionine De Novo and Salvage Pathway WP3580,0.6855939487673667,0.902245250431779,0.3405702782225799,['ODC1'],0.9965465294843274,0,0,1
174,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6855939487673667,0.902245250431779,0.3405702782225799,['NDUFA13'],0.9965465294843274,0,0,1
175,IL-18 signaling pathway WP4754,0.6987583932200667,0.8636830906787157,0.30958741357418545,"['TOMM40', 'NACA', 'BAD', 'CYCS', 'NDUFC1', 'RND2', 'AARS']",0.9965465294843274,0,0,7
176,EGF/EGFR signaling pathway WP437,0.7036156264239276,0.8383397932816538,0.29469576704103184,"['NDUFA13', 'AP2S1', 'NEDD8', 'AP2M1']",0.9965465294843274,0,0,4
177,Toll-like Receptor Signaling Pathway WP75,0.7068190011407363,0.819754639823844,0.28443900232735647,"['IRF3', 'TRAF3']",0.9965465294843274,0,0,2
178,Allograft Rejection WP2328,0.7170181698040874,0.8200659444182761,0.2727982964466865,['HLA-B'],0.9965465294843274,0,0,1
179,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.7170181698040874,0.8200659444182761,0.2727982964466865,['IRF3'],0.9965465294843274,0,0,1
180,Lung fibrosis WP3624,0.7170181698040874,0.8200659444182761,0.2727982964466865,['FGF1'],0.9965465294843274,0,0,1
181,miRNA regulation of prostate cancer signaling pathways WP3981,0.7170181698040874,0.8200659444182761,0.2727982964466865,['BAD'],0.9965465294843274,0,0,1
182,Notch Signaling WP268,0.7170181698040874,0.8200659444182761,0.2727982964466865,['APH1A'],0.9965465294843274,0,0,1
183,Pre-implantation embryo WP3527,0.7170181698040874,0.8200659444182761,0.2727982964466865,['DDIT3'],0.9965465294843274,0,0,1
184,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.7281511586737055,0.7839626899353092,0.24870951107777542,"['BAD', 'RPS6']",0.9965465294843274,0,0,2
185,Circadian rhythm related genes WP3594,0.7283954924970919,0.8188142292490118,0.25949133394950197,"['PRKCG', 'NAMPT', 'CRH', 'RPS27A', 'UBA52']",0.9965465294843274,0,0,5
186,Splicing factor NOVA regulated synaptic proteins WP4148,0.7453064632427447,0.7515831894070236,0.22093523286582553,['NTNG1'],0.9965465294843274,0,0,1
187,The influence of laminopathies on Wnt signaling WP4844,0.7453064632427447,0.7515831894070236,0.22093523286582553,['ZMPSTE24'],0.9965465294843274,0,0,1
188,DNA Replication WP466,0.7453064632427447,0.7515831894070236,0.22093523286582553,['UBA52'],0.9965465294843274,0,0,1
189,Folate Metabolism WP176,0.7453064632427447,0.7515831894070236,0.22093523286582553,['GPX4'],0.9965465294843274,0,0,1
190,IL-2 signaling pathway WP49,0.7453064632427447,0.7515831894070236,0.22093523286582553,['RPS6'],0.9965465294843274,0,0,1
191,Integrated Cancer Pathway WP1971,0.7453064632427447,0.7515831894070236,0.22093523286582553,['BAD'],0.9965465294843274,0,0,1
192,Intraflagellar transport proteins binding to dynein WP4532,0.7453064632427447,0.7515831894070236,0.22093523286582553,['WDR34'],0.9965465294843274,0,0,1
193,MAPK Cascade WP422,0.7453064632427447,0.7515831894070236,0.22093523286582553,['MBP'],0.9965465294843274,0,0,1
194,Oxysterols derived from cholesterol WP4545,0.7453064632427447,0.7515831894070236,0.22093523286582553,['EPHX2'],0.9965465294843274,0,0,1
195,Peptide GPCRs WP24,0.7453064632427447,0.7515831894070236,0.22093523286582553,['MC1R'],0.9965465294843274,0,0,1
196,"GPCRs, Class A Rhodopsin-like WP455",0.7457280645975527,0.7723198811587026,0.22659422766320494,"['MC1R', 'HTR5A', 'MCHR1']",0.9965465294843274,0,0,3
197,Head and Neck Squamous Cell Carcinoma WP4674,0.7481535084248109,0.7511534025374856,0.21794497907025775,"['TRAF3', 'RPS6']",0.9965465294843274,0,0,2
198,Fragile X Syndrome  WP4549,0.7491433574762846,0.7832125603864735,0.22621130139951137,"['DEPTOR', 'ALDH5A1', 'AP2S1', 'AP2M1']",0.9965465294843274,0,0,4
199,Hippo-Merlin Signaling Dysregulation WP4541,0.7616339219371898,0.7507221259387638,0.20441356923833057,"['CDH11', 'NF2', 'STK3']",0.9965465294843274,0,0,3
200,Integrated breast cancer pathway WP1984,0.76307418845166,0.7664007092198581,0.20723476698876864,"['FER', 'BAD', 'ODC1', 'FAU']",0.9965465294843274,0,0,4
201,TNF-alpha signaling pathway WP231,0.7668785803633448,0.7209688581314879,0.191364453133745,"['BAD', 'KSR2']",0.9965465294843274,0,0,2
202,Vitamin D-sensitive calcium signaling in depression WP4698,0.7707712866682807,0.6936362428590408,0.18059762544841357,['GPX4'],0.9965465294843274,0,0,1
203,Interleukin-11 Signaling Pathway WP2332,0.7707712866682807,0.6936362428590408,0.18059762544841357,['RPS6'],0.9965465294843274,0,0,1
204,Monoamine GPCRs WP58,0.7707712866682807,0.6936362428590408,0.18059762544841357,['HTR5A'],0.9965465294843274,0,0,1
205,Mesodermal commitment pathway WP2857,0.7767244416853373,0.7302918169469296,0.1845225671390127,"['LEFTY1', 'TRIM28', 'RPL38']",0.9965465294843274,0,0,3
206,Focal Adhesion WP306,0.7792030636455617,0.7627118644067796,0.19028409778847497,"['PRKCG', 'BAD', 'COL4A4', 'PDGFC', 'TLN1']",0.9965465294843274,0,0,5
207,MAPK Signaling Pathway WP382,0.7835182211074193,0.7711299153807865,0.18812559553322675,"['PRKCG', 'DUSP4', 'DDIT3', 'RASGRF2', 'FGF1', 'STK3']",0.9965465294843274,0,0,6
208,Corticotropin-releasing hormone signaling pathway WP2355,0.7843816701631503,0.6931062017567208,0.1683274622739648,"['TRIM28', 'CRH']",0.9965465294843274,0,0,2
209,Copper homeostasis WP3286,0.7936940134610716,0.6439674315321984,0.14879335379133363,['ATOX1'],0.9965465294843274,0,0,1
210,Genotoxicity pathway WP4286,0.7936940134610716,0.6439674315321984,0.14879335379133363,['RPS27'],0.9965465294843274,0,0,1
211,Glycogen Synthesis and Degradation WP500,0.7936940134610716,0.6439674315321984,0.14879335379133363,['PHKG1'],0.9965465294843274,0,0,1
212,IL-5 signaling pathway WP127,0.7936940134610716,0.6439674315321984,0.14879335379133363,['RPS6'],0.9965465294843274,0,0,1
213,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7936940134610716,0.6439674315321984,0.14879335379133363,['PRKCG'],0.9965465294843274,0,0,1
214,TGF-beta Receptor Signaling WP560,0.8143280204555896,0.6009211283822683,0.12342440479105916,['LEFTY1'],0.9965465294843274,0,0,1
215,Wnt Signaling Pathway WP363,0.8143280204555896,0.6009211283822683,0.12342440479105916,['PRKCG'],0.9965465294843274,0,0,1
216,Disruption of postsynaptic signaling by CNV WP4875,0.8143280204555896,0.6009211283822683,0.12342440479105916,['DLG1'],0.9965465294843274,0,0,1
217,G13 Signaling Pathway WP524,0.8143280204555896,0.6009211283822683,0.12342440479105916,['ARHGDIG'],0.9965465294843274,0,0,1
218,IL-3 signaling pathway WP286,0.8143280204555896,0.6009211283822683,0.12342440479105916,['BAD'],0.9965465294843274,0,0,1
219,Pathogenic Escherichia coli infection WP2272,0.8143280204555896,0.6009211283822683,0.12342440479105916,['ARPC3'],0.9965465294843274,0,0,1
220,Leptin signaling pathway WP2034,0.8159506667740886,0.643351458230351,0.13085857650731406,"['BAD', 'RPS6']",0.9965465294843274,0,0,2
221,Osteoblast differentiation WP4787,0.8301322467358554,0.6210476076840472,0.11562059302181642,"['PRKCG', 'FGF1']",0.9965465294843274,0,0,2
222,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.8329014690361088,0.5632556131260794,0.10298561590835652,['ZMPSTE24'],0.9965465294843274,0,0,1
223,Common Pathways Underlying Drug Addiction WP2636,0.8329014690361088,0.5632556131260794,0.10298561590835652,['PRKCG'],0.9965465294843274,0,0,1
224,IL-6 signaling pathway WP364,0.8329014690361088,0.5632556131260794,0.10298561590835652,['BAD'],0.9965465294843274,0,0,1
225,p38 MAPK Signaling Pathway WP400,0.8329014690361088,0.5632556131260794,0.10298561590835652,['DDIT3'],0.9965465294843274,0,0,1
226,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.8496198109438642,0.5300213349588541,0.08637562160373713,['DLG1'],0.9965465294843274,0,0,1
227,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8496198109438642,0.5300213349588541,0.08637562160373713,['LEFTY1'],0.9965465294843274,0,0,1
228,Interferon type I signaling pathways WP585,0.8496198109438642,0.5300213349588541,0.08637562160373713,['RPS6'],0.9965465294843274,0,0,1
229,Ras signaling WP4223,0.8626482388621164,0.6421130952380952,0.09487110134178006,"['PRKCG', 'BAD', 'RASGRF2', 'KSR2']",0.9965465294843274,0,0,4
230,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.8646680446478284,0.5004797543657648,0.07277456545439724,['MBP'],0.9965465294843274,0,0,1
231,Notch Signaling Pathway Netpath WP61,0.8646680446478284,0.5004797543657648,0.07277456545439724,['APH1A'],0.9965465294843274,0,0,1
232,PPAR signaling pathway WP3942,0.8646680446478284,0.5004797543657648,0.07277456545439724,['CPT1B'],0.9965465294843274,0,0,1
233,Rett syndrome causing genes WP4312,0.8646680446478284,0.5004797543657648,0.07277456545439724,['GPS2'],0.9965465294843274,0,0,1
234,Thermogenesis WP4321,0.8669494431612706,0.5625,0.08031072166194722,"['RPS6', 'CPT1B']",0.9965465294843274,0,0,2
235,Androgen receptor signaling pathway WP138,0.877495788492249,0.5453496906784104,0.07126800075547407,"['SUMO1', 'PARK7']",0.9965465294843274,0,0,2
236,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.8782127489147855,0.4740478138351059,0.0615628848417229,['RPS6'],0.9965465294843274,0,0,1
237,"GPCRs, Other WP117",0.8782127489147855,0.4740478138351059,0.0615628848417229,['CELSR2'],0.9965465294843274,0,0,1
238,IL-4 signaling pathway WP395,0.8782127489147855,0.4740478138351059,0.0615628848417229,['BAD'],0.9965465294843274,0,0,1
239,Genes related to primary cilium development (based on CRISPR) WP4536,0.8872664767314031,0.5292082230816202,0.06329855167325746,"['CEP120', 'WDR34']",0.9965465294843274,0,0,2
240,IL-1 signaling pathway WP195,0.8904039134104045,0.450259067357513,0.05226611032255278,['SQSTM1'],0.9965465294843274,0,0,1
241,Proximal tubule transport WP4917,0.8904039134104045,0.450259067357513,0.05226611032255278,['ATP6V1F'],0.9965465294843274,0,0,1
242,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8904039134104045,0.450259067357513,0.05226611032255278,['BAD'],0.9965465294843274,0,0,1
243,TGF-beta Signaling Pathway WP366,0.8963109919037531,0.5139891250617894,0.056265277787954565,"['PARD6A', 'SUMO1']",0.9965465294843274,0,0,2
244,Wnt signaling pathway and pluripotency WP399,0.9013765885116474,0.4287359157825479,0.04451656824205015,['PRKCG'],0.9965465294843274,0,0,1
245,DNA damage response WP707,0.9013765885116474,0.4287359157825479,0.04451656824205015,['CYCS'],0.9965465294843274,0,0,1
246,Neural Crest Differentiation WP2064,0.9013765885116474,0.4287359157825479,0.04451656824205015,['MBP'],0.9965465294843274,0,0,1
247,Myometrial relaxation and contraction pathways WP289,0.9070594542195973,0.5793010752688172,0.05650924454567089,"['PRKCG', 'GRK4', 'GSTO1', 'CRH']",0.9965465294843274,0,0,4
248,miRNA regulation of DNA damage response WP1530,0.911252370750355,0.4091694143507615,0.038026320742054885,['CYCS'],0.9965465294843274,0,0,1
249,Prolactin Signaling Pathway WP2037,0.911252370750355,0.4091694143507615,0.038026320742054885,['RPS6'],0.9965465294843274,0,0,1
250,Pathways in clear cell renal cell carcinoma WP4018,0.9124086974142981,0.4860188908631815,0.04455201816723545,"['DEPTOR', 'SQSTM1']",0.9965465294843274,0,0,2
251,Ectoderm Differentiation WP2858,0.9167409765014282,0.5283922927923336,0.04593330845651508,"['ARHGDIG', 'NF2', 'CELSR2']",0.9965465294843274,0,0,3
252,AGE/RAGE pathway WP2324,0.9201407411806386,0.391304347826087,0.0325677291241523,['CYCS'],0.9965465294843274,0,0,1
253,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.9201407411806386,0.391304347826087,0.0325677291241523,['RPS6'],0.9965465294843274,0,0,1
254,Oncostatin M Signaling Pathway WP2374,0.9201407411806386,0.391304347826087,0.0325677291241523,['RPS6'],0.9965465294843274,0,0,1
255,Gastrin signaling pathway WP4659,0.9322206297111398,0.44930795847750865,0.031535022855580824,"['BAD', 'RPS6']",0.9965465294843274,0,0,2
256,Endoderm differentiation WP2853,0.9378247877357387,0.4382648324753144,0.02813315787018129,"['DUSP4', 'TCEAL2']",0.9965465294843274,0,0,2
257,Joubert Syndrome WP4656,0.9418189432336548,0.3459545635711439,0.02073728715930883,['CEP120'],0.9965465294843274,0,0,1
258,Retinoblastoma gene in cancer WP2446,0.9418189432336548,0.3459545635711439,0.02073728715930883,['H2AFZ'],0.9965465294843274,0,0,1
259,NRF2 pathway WP2884,0.9429877218600835,0.42774756961608174,0.025109644987940057,"['GSTP1', 'SQSTM1']",0.9965465294843274,0,0,2
260,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.943073506009213,0.5715768403884647,0.03350071892984134,"['PIK3IP1', 'BAD', 'COL4A4', 'PDGFC', 'RPS6', 'FGF1']",0.9965465294843274,0,0,6
261,Wnt signaling WP428,0.9476499182055095,0.3330774643382588,0.01790961839859609,['PRKCG'],0.9965465294843274,0,0,1
262,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9476499182055095,0.3330774643382588,0.01790961839859609,['SLC38A2'],0.9965465294843274,0,0,1
263,Endochondral Ossification WP474,0.9476499182055095,0.3330774643382588,0.01790961839859609,['SLC38A2'],0.9965465294843274,0,0,1
264,AMP-activated protein kinase (AMPK) signaling WP1403,0.9528973889538507,0.3211201579077227,0.015493422313596798,['CPT1B'],0.9965465294843274,0,0,1
265,Melanoma WP4685,0.9528973889538507,0.3211201579077227,0.015493422313596798,['BAD'],0.9965465294843274,0,0,1
266,DNA IR-damage and cellular response via ATR WP4016,0.9576196555945631,0.30998749329998215,0.013423884109924275,['TRIM28'],0.9965465294843274,0,0,1
267,ESC Pluripotency Pathways WP3931,0.9576196555945631,0.30998749329998215,0.013423884109924275,['FGF1'],0.9965465294843274,0,0,1
268,Glioblastoma signaling pathways WP2261,0.9576196555945631,0.30998749329998215,0.013423884109924275,['PRKCG'],0.9965465294843274,0,0,1
269,Calcium Regulation in the Cardiac Cell WP536,0.9581914300526065,0.4483535528596187,0.019148148299214823,"['PRKCG', 'GRK4', 'ATP1B2']",0.9965465294843274,0,0,3
270,Spinal Cord Injury WP2431,0.9618692023588955,0.29959700633275765,0.011647373448345348,['MBP'],0.9965465294843274,0,0,1
271,Pancreatic adenocarcinoma pathway WP4263,0.9618692023588955,0.29959700633275765,0.011647373448345348,['BAD'],0.9965465294843274,0,0,1
272,Ciliopathies WP4803,0.9670141672670043,0.4267557976396798,0.014314299678009956,"['CEP120', 'WDR34', 'SPATA7']",0.9965465294843274,0,0,3
273,Integrin-mediated Cell Adhesion WP185,0.9691344113844431,0.2807642487046632,0.008802510974968225,['TLN1'],0.9965465294843274,0,0,1
274,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.9691344113844431,0.2807642487046632,0.008802510974968225,['PSMC5'],0.9965465294843274,0,0,1
275,PI3K-Akt signaling pathway WP4172,0.9693037315205942,0.4914476827520306,0.015321996007182153,"['BAD', 'COL4A4', 'PDGFC', 'RPS6', 'FGF1']",0.9965465294843274,0,0,5
276,DNA damage response (only ATM dependent) WP710,0.9750171891363065,0.2641471096210505,0.006682968959299821,['BAD'],0.9965465294843274,0,0,1
277,G Protein Signaling Pathways WP35,0.9750171891363065,0.2641471096210505,0.006682968959299821,['PRKCG'],0.9965465294843274,0,0,1
278,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.98808813230422,0.21875394919752306,0.0026214122412670233,['COL4A4'],0.9965465294843274,0,0,1
279,Breast cancer pathway WP4262,0.9892848519261322,0.21350440003289745,0.0023000762149184614,['FGF1'],0.9965465294843274,0,0,1
280,Chemokine signaling pathway WP3929,0.9922015085100421,0.19915563231625408,0.0015592011452844555,['GRK4'],0.9965465294843274,0,0,1
281,Regulation of Actin Cytoskeleton WP51,0.9929854291605225,0.19478861605466696,0.0013711732842047407,['FGF1'],0.9965465294843274,0,0,1
282,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9954090720789387,0.17906735751295336,0.0008239781941604658,['SST'],0.9965465294843274,0,0,1
283,Insulin Signaling WP481,0.9958708467582319,0.17552236784178266,0.0007262592059777017,['RAB4A'],0.9965465294843274,0,0,1
284,Nuclear Receptors Meta-Pathway WP2882,0.9965465294843274,0.2971692663200462,0.0010280414783768847,"['PSMC5', 'GSTP1', 'SQSTM1']",0.9965465294843274,0,0,3
